Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 33%
Hold 42%
Sell 17%
Strong Sell 0%

Bulls say

CME Group has demonstrated robust growth across its international markets, achieving record quarterly volume with notable increases of 15% in EMEA and 30% in APAC year-over-year. The company has also significantly expanded its retail base, adding over 90,000 new traders, which reflects a 56% increase year-over-year and marks the fifth consecutive quarter of double-digit growth in this segment. These positive metrics indicate strong demand and an expanding user base, contributing to a favorable outlook for CME Group's stock.

Bears say

CME Group's outlook is negatively impacted by the consistent decline in open interest (OI), which poses a risk of deteriorating market sentiment and financial conditions. Additionally, the company is highly leveraged to market volumes, making it susceptible to fluctuations in market volatility, which could further depress trading activity. The current elevated trading volumes, driven by geopolitical tensions and tariff uncertainties, may not be sustainable, highlighting the potential vulnerabilities in CME’s revenue streams.

CME Group (CME) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 33% recommend Buy, 42% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 12 analysts, CME Group (CME) has a Hold consensus rating as of Oct 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $275.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $275.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.